Press releases

Month Year

Email alerts

Jan 14, 2021

Medtronic Launches First-of-Its-Kind Adaptive Deep Brain Stimulation (aDBS) Trial in Parkinson's Disease Patients

ADAPT-PD Global Study Designed to Demonstrate Safety & Efficacy of Automated Therapy Which Responds to Brain Signals in Parkinson's Disease Patients DUBLIN, Jan. 14, 2021 /PRNewswire/ -- Medtronic...
Dec 15, 2020

Medtronic's OsteoCool™ Procedure Shows Significant, Swift Pain Relief and Sustained Improvement for Cancer Patients

The OPuS One Clinical Study is the largest study with the most meaningful clinical results supporting the OsteoCool™ Technology to-date

Medtronic plc (NYSE: MDT) today announced the release of outcomes in the first 100 patients treated with the OsteoCool™ Radiofrequency Ablation (RFA) System in the OPuS One Clinical Study (as...
- Photos 1
Nov 16, 2020

Medtronic Completes Acquisition of Medicrea

Acquisition Expands Medtronic's Artificial Intelligence and Data Capabilities, Becoming the First Company to Offer an Integrated Spine Solution Including AI-Driven Surgical Planning, Personalized...
Oct 29, 2020

Medtronic Expands ENT Portfolio with FDA Clearance of NIM Vital™ Next Generation Intraoperative Nerve Monitoring System and Acquisition of Ai Biomed Corp.

New Technologies Address Most Common Challenges During Head and Neck Surgery

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the NIM Vital™ nerve monitoring...
Oct 20, 2020

Patients Report Superior, Sustained and Profound Back Pain Relief at 12 Months with DTM™ Spinal Cord Stimulation Therapy Using the Medtronic Intellis™ Platform

Study Reports 84% Back Pain Responder Rate and 69% Profound Responder Rate at 12 Months(1)

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced statistically significant 12-month results from a large, multicenter randomized controlled trial (RCT) that...
- Photos 1

Show per page